Back to Ovarian Cancer
NCT00987649
NCT00987649
Who may be able to join
Who might be able to join this trial:
- You are a woman aged 18 or older
- You have a mass (a growth or lump) near your ovaries or in your pelvic area, confirmed by an imaging scan such as an ultrasound
- You are already scheduled to have surgery because of this mass (which may be a simple, complex, or solid cyst, or any similar growth in the pelvic area)
- You are able to understand the study information and are willing to sign a consent form agreeing to take part
Who may not be able to join:
- You have previously been diagnosed with ovarian cancer
- You have previously had both of your ovaries removed
- You are currently pregnant
- You are unable to understand or sign the consent form agreeing to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Fujirebio Diagnostics, Inc.
Registry
clinicaltrials_gov
Start date
1 October 2009
Est. completion
1 August 2010
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
1. A statistically higher number of cancer patients are correctly assigned by the combination of Initial Cancer Risk assessment and positive ROMA test result than by Initial Cancer Risk assessment alone
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.